Skip to main content
Premium Trial:

Request an Annual Quote

NCI Starts $10M SBIR Bridge Program

NEW YORK (GenomeWeb News) – Small, early-stage companies focused on developing cancer imaging technologies or cancer therapies that have received Phase II funding from the National Cancer Institute’s Small Business Innovation Research program will have access to greater funding from NCI in 2009.
The NCI Small Business Innovation Research Bridge Award program “more than triples” the amount of funding small businesses can seek through the NCI SBIR program, NCI said today.
NCI expects the SBIR Bridge Award program to run for a three- to five-year pilot phase, and it will be funded with $10 million in fiscal 2009 and in each of the subsequent years. Under the Bridge Award, small businesses may apply for up to $3 million over three years.
The aim of the program is to help companies get through a “critical phase of development” and to reduce the risk investors face.
NCI also expects the Bridge Award amounts to be matched by non-federal funds.
More information can be found at the NCI’s website.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.